Within the scope of our office activities, we assume the operative tasks of the German Bioeconomy Council, an advisory body of the Federal Government. The main function of the office is the continuous support of the committee in all administrative, organizational and technical matters.
For the second time, BIOCOM organised the Global Bioeconomy Summit with 800 bioeconomy, innovation and sustainability experts from all over the world. The event was hosted by the Bioeconomy Council of the German Federal Government.
Our event video and livestream made it possible: Even those who could not travel to Berlin had the opportunity to experience the Global Bioeconomy Summit 2018 up close.
The ENABLE project, part of the New Drugs for Bad Bugs (ND4BB) IMI programme, is working to promote the development of potential antibiotics against gram-negative bacteria such as Escherichia coli. The ultimate goal of the project is to develop attractive antimicrobial candidates for clinical testing that bring the possibility of new antibiotics for the treatment of gram-negative infections one step closer to the patient.
The primary objective of the strategy process – initiated by the BMBF – was to establish interdisciplinary links between actors and motivate them to start joint R&D projects. Above all, representatives of the engineering disciplines should be encouraged to consider the use of biotechnological processes and to work together with natural scientists on appropriate solutions.